Symbols / ISPC $0.15 +7.52% iSpecimen Inc.

Healthcare • Diagnostics & Research • United States • NCM
ISPC Chart
About

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; Solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and Hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. The company serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Diagnostics & Research Market Cap 1.49M
Enterprise Value -2.39M Income -10.49M Sales 1.93M
Book/sh 0.31 Cash/sh 0.23 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -0.19 PEG —
P/S 0.77 P/B 0.49 P/C —
EV/EBITDA 0.28 EV/Sales -1.24 Quick Ratio 1.11
Current Ratio 1.12 Debt/Eq 8.70 LT Debt/Eq —
EPS (ttm) -2.28 EPS next Y -0.79 EPS Growth —
Revenue Growth -96.50% Earnings 2024-08-06 09:00 ROA -59.44%
ROE -3.28% ROIC — Gross Margin 1.25%
Oper. Margin -51.93% Profit Margin 0.00% Shs Outstand 9.77M
Shs Float 29.66M Short Float 31.46% Short Ratio 0.18
Short Interest — 52W High 3.18 52W Low 0.14
Beta — Avg Volume 7.90M Volume 4.71M
Target Price — Recom None Prev Close $0.14
Price $0.15 Change 7.52%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.15
Latest analyst target
3. DCF / Fair value
$-5.17
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.15
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2022-09-23 main EF Hutton — → Buy $4
2022-01-04 init Craig-Hallum — → Buy $20
2021-11-22 main EF Hutton — → Buy $12
News
RSS: Latest ISPC news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1.93
-79.24%
9.29
-6.42%
9.93
-4.56%
10.40
Operating Revenue
1.93
-79.24%
9.29
-6.42%
9.93
-4.56%
10.40
Cost Of Revenue
1.90
-64.08%
5.30
+10.01%
4.82
+1.33%
4.76
Reconciled Cost Of Revenue
1.90
-64.08%
5.30
+10.01%
4.82
+1.33%
4.76
Gross Profit
0.02
-99.40%
3.99
-21.92%
5.11
-9.52%
5.65
Operating Expense
9.00
-46.15%
16.72
+2.70%
16.28
+2.82%
15.83
Research And Development
2.16
-38.82%
3.53
-1.03%
3.57
+34.28%
2.66
Selling General And Administration
6.60
-47.86%
12.65
+8.29%
11.68
-5.61%
12.37
Selling And Marketing Expense
2.30
-53.58%
4.95
+25.01%
3.96
+14.82%
3.45
General And Administrative Expense
4.30
-44.18%
7.70
-0.27%
7.72
-13.49%
8.93
Other Gand A
4.30
-44.18%
7.70
-0.27%
7.72
-13.49%
8.93
Other Operating Expenses
0.25
-54.08%
0.54
-47.80%
1.03
+28.62%
0.80
Total Expenses
10.91
-50.47%
22.02
+4.37%
21.10
+2.47%
20.59
Operating Income
-8.98
+29.46%
-12.73
-13.96%
-11.17
-9.65%
-10.19
Total Operating Income As Reported
-8.98
+29.46%
-12.73
-13.96%
-11.17
-9.65%
-10.19
EBITDA
-8.75
+12.39%
-9.98
-14.05%
-8.75
+0.55%
-8.80
Normalized EBITDA
-8.75
+12.39%
-9.98
-14.05%
-8.75
+0.55%
-8.80
Reconciled Depreciation
1.73
-24.55%
2.29
+8.47%
2.12
+75.50%
1.21
EBIT
-10.48
+14.66%
-12.28
-12.96%
-10.87
-8.61%
-10.01
Total Unusual Items
—
—
—
0.00
Total Unusual Items Excluding Goodwill
—
—
—
0.00
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
-10.49
+16.09%
-12.50
-12.60%
-11.10
-8.33%
-10.25
Pretax Income
-10.49
+16.09%
-12.50
-12.60%
-11.10
-8.33%
-10.25
Net Non Operating Interest Income Expense
-0.01
+96.49%
-0.18
-261.47%
0.11
+256.52%
-0.07
Interest Expense Non Operating
0.01
-95.49%
0.22
-4.64%
0.23
-3.42%
0.24
Net Interest Income
-0.01
+96.49%
-0.18
-261.47%
0.11
+256.52%
-0.07
Interest Expense
0.01
-95.49%
0.22
-4.64%
0.23
-3.42%
0.24
Interest Income Non Operating
0.00
-91.51%
0.04
-87.01%
0.34
+100.63%
0.17
Interest Income
0.00
-91.51%
0.04
-87.01%
0.34
+100.63%
0.17
Other Income Expense
-1.50
-470.14%
0.41
+1138.72%
-0.04
-499.92%
0.01
Other Non Operating Income Expenses
-1.50
-470.14%
0.41
+1138.72%
-0.04
-499.92%
0.01
Gain On Sale Of Security
—
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-10.49
+16.09%
-12.50
-12.60%
-11.10
-8.33%
-10.25
Net Income From Continuing Operation Net Minority Interest
-10.49
+16.09%
-12.50
-12.60%
-11.10
-8.33%
-10.25
Net Income From Continuing And Discontinued Operation
-10.49
+16.09%
-12.50
-12.60%
-11.10
-8.33%
-10.25
Net Income Continuous Operations
-10.49
+16.09%
-12.50
-12.60%
-11.10
-8.33%
-10.25
Normalized Income
-10.49
+16.09%
-12.50
-12.60%
-11.10
-8.33%
-10.25
Net Income Common Stockholders
-10.49
+16.09%
-12.50
-12.60%
-11.10
-8.33%
-10.25
Diluted EPS
—
-17.58
+28.39%
-24.55
-5.82%
-23.20
Basic EPS
—
-17.58
+28.39%
-24.55
-5.82%
-23.20
Basic Average Shares
—
0.71
+57.24%
0.45
+2.23%
0.44
Diluted Average Shares
—
0.71
+57.24%
0.45
+2.23%
0.44
Diluted NI Availto Com Stockholders
-10.49
+16.09%
-12.50
-12.60%
-11.10
-8.33%
-10.25
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
9.53
+1.94%
9.35
-40.89%
15.82
-35.74%
24.62
Current Assets
6.95
+93.83%
3.59
-56.45%
8.24
-58.13%
19.68
Cash Cash Equivalents And Short Term Investments
6.88
+266.31%
1.88
-62.47%
5.01
-67.30%
15.31
Cash And Cash Equivalents
6.88
+266.31%
1.88
-19.85%
2.34
-84.69%
15.31
Cash Financial
—
—
—
15.31
Other Short Term Investments
—
0.00
-100.00%
2.66
0.00
Receivables
0.05
-96.66%
1.44
-50.88%
2.94
-27.68%
4.07
Accounts Receivable
0.05
-96.66%
1.44
+98.33%
0.73
-54.42%
1.60
Gross Accounts Receivable
0.69
-66.38%
2.07
+65.30%
1.25
-31.69%
1.83
Allowance For Doubtful Accounts Receivable
-0.65
-4.13%
-0.62
-19.11%
-0.52
-125.50%
-0.23
Other Receivables
—
—
2.21
-4.95%
2.33
Taxes Receivable
—
—
0.00
-100.00%
0.14
Inventory
0.00
-100.00%
0.05
—
—
Prepaid Assets
—
—
—
—
Other Current Assets
0.03
-88.42%
0.22
-24.75%
0.29
-2.78%
0.30
Total Non Current Assets
2.58
-55.28%
5.76
-23.99%
7.58
+53.39%
4.94
Net PPE
0.29
-30.09%
0.42
+31.06%
0.32
-21.65%
0.41
Gross PPE
0.71
-7.64%
0.76
-0.36%
0.77
+3.88%
0.74
Accumulated Depreciation
-0.41
-20.02%
-0.34
+23.08%
-0.44
-35.93%
-0.33
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.27
-17.93%
0.33
+69.19%
0.19
+4.96%
0.18
Machinery Furniture Equipment
0.12
+0.38%
0.12
-35.43%
0.18
+6.66%
0.17
Other Properties
0.30
+0.00%
0.30
-5.04%
0.32
+0.00%
0.32
Leases
0.01
+0.00%
0.01
-81.53%
0.07
+13.29%
0.06
Goodwill And Other Intangible Assets
2.27
-57.40%
5.33
-26.31%
7.23
+60.56%
4.50
Other Intangible Assets
2.27
-57.40%
5.33
-26.31%
7.23
+60.56%
4.50
Non Current Prepaid Assets
0.01
+0.00%
0.01
-56.16%
0.03
+0.00%
0.03
Total Liabilities Net Minority Interest
6.44
+6.69%
6.04
-0.64%
6.08
+41.07%
4.31
Current Liabilities
6.23
+7.99%
5.77
-4.60%
6.05
+41.29%
4.28
Payables And Accrued Expenses
5.98
+11.47%
5.37
-1.82%
5.47
+36.98%
3.99
Payables
5.36
+27.76%
4.20
+6.93%
3.93
+59.63%
2.46
Accounts Payable
5.36
+27.76%
4.20
+6.93%
3.93
+59.63%
2.46
Current Accrued Expenses
0.62
-47.02%
1.17
-24.13%
1.54
+0.61%
1.53
Current Debt And Capital Lease Obligation
0.06
+31.26%
0.04
-74.05%
0.17
+5.47%
0.16
Current Capital Lease Obligation
0.06
+31.26%
0.04
-74.05%
0.17
+5.47%
0.16
Current Deferred Liabilities
0.19
-46.62%
0.36
-13.24%
0.42
+214.18%
0.13
Current Deferred Revenue
0.19
-46.62%
0.36
-13.24%
0.42
+214.18%
0.13
Total Non Current Liabilities Net Minority Interest
0.21
-21.18%
0.27
+822.75%
0.03
+6.33%
0.03
Long Term Debt And Capital Lease Obligation
0.21
-21.18%
0.27
+822.75%
0.03
+6.33%
0.03
Long Term Debt
—
—
—
—
Long Term Capital Lease Obligation
0.21
-21.18%
0.27
+822.75%
0.03
+6.33%
0.03
Stockholders Equity
3.09
-6.73%
3.31
-66.01%
9.74
-52.04%
20.31
Common Stock Equity
3.09
-6.73%
3.31
-66.01%
9.74
-52.04%
20.31
Capital Stock
0.00
+399.41%
0.00
+277.78%
0.00
-94.96%
0.00
Common Stock
0.00
+398.82%
0.00
+277.78%
0.00
-94.96%
0.00
Preferred Stock
0.00
0.00
—
—
Share Issued
10.04
+491.12%
1.70
+272.70%
0.46
+1.76%
0.45
Ordinary Shares Number
10.04
+491.57%
1.70
+273.63%
0.45
+1.77%
0.45
Treasury Shares Number
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Additional Paid In Capital
85.44
+13.65%
75.17
+8.78%
69.11
+0.77%
68.57
Retained Earnings
-82.35
-14.59%
-71.86
-21.05%
-59.36
-23.00%
-48.27
Gains Losses Not Affecting Retained Earnings
0.00
0.00
-100.00%
0.00
0.00
Treasury Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Other Equity Adjustments
—
—
0.00
—
Total Equity Gross Minority Interest
3.09
-6.73%
3.31
-66.01%
9.74
-52.04%
20.31
Total Capitalization
3.09
-6.73%
3.31
-66.01%
9.74
-52.04%
20.31
Working Capital
0.72
+133.14%
-2.18
-199.67%
2.19
-85.78%
15.39
Invested Capital
3.09
-6.73%
3.31
-66.01%
9.74
-52.04%
20.31
Total Debt
0.27
-13.89%
0.31
+59.07%
0.20
+5.59%
0.19
Capital Lease Obligations
0.27
-13.89%
0.31
+59.07%
0.20
+5.59%
0.19
Net Tangible Assets
0.82
+140.55%
-2.02
-180.39%
2.51
-84.12%
15.81
Tangible Book Value
0.82
+140.55%
-2.02
-180.39%
2.51
-84.12%
15.81
Interest Payable
—
—
—
0.00
Preferred Stock Equity
0.00
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.24
+48.68%
-8.26
-42.29%
-5.81
+0.17%
-5.82
Cash Flow From Continuing Operating Activities
-4.24
+48.68%
-8.26
-42.29%
-5.81
+0.17%
-5.82
Net Income From Continuing Operations
-10.49
+16.09%
-12.50
-12.60%
-11.10
-8.33%
-10.25
Depreciation Amortization Depletion
1.73
-24.55%
2.29
+8.47%
2.12
+75.50%
1.21
Depreciation
0.07
+4.20%
0.07
-44.10%
0.12
+423.97%
0.02
Amortization Cash Flow
1.66
-25.40%
2.23
+11.56%
2.00
+68.89%
1.18
Depreciation And Amortization
1.73
-24.55%
2.29
+8.47%
2.12
+75.50%
1.21
Amortization Of Intangibles
1.66
-25.40%
2.23
+11.56%
2.00
+68.89%
1.18
Other Non Cash Items
-0.07
-158.83%
-0.03
+83.66%
-0.18
-311.99%
0.08
Stock Based Compensation
0.02
-91.48%
0.25
-45.68%
0.46
-32.26%
0.68
Asset Impairment Charge
2.46
+10.58%
2.22
+628.13%
0.31
+186.20%
0.11
Operating Gains Losses
—
0.00
—
—
Gain Loss On Investment Securities
—
0.00
—
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.00
0.00
—
Change In Working Capital
2.11
+520.49%
-0.50
-119.41%
2.59
+9.99%
2.35
Change In Receivables
1.34
+436.31%
-0.40
-148.43%
0.82
+15.71%
0.71
Changes In Account Receivables
1.34
+247.95%
-0.90
-260.03%
0.56
-56.51%
1.30
Change In Inventory
0.05
0.00
—
—
Change In Prepaid Assets
0.19
+355.22%
0.04
+410.93%
0.01
-68.59%
0.03
Change In Payables And Accrued Expense
0.69
+792.59%
-0.10
-106.76%
1.48
-31.03%
2.14
Change In Accrued Expense
-0.55
-47.80%
-0.37
-4068.63%
0.01
-98.17%
0.51
Change In Payable
1.24
+355.69%
0.27
-81.44%
1.47
-9.84%
1.63
Change In Account Payable
1.24
+355.69%
0.27
-81.44%
1.47
-9.84%
1.63
Change In Other Working Capital
-0.17
-205.42%
-0.06
-119.43%
0.28
+154.26%
-0.52
Change In Other Current Assets
0.06
-53.69%
0.13
-19.20%
0.16
+5.90%
0.15
Change In Other Current Liabilities
-0.04
+63.92%
-0.12
+22.93%
-0.16
-5.90%
-0.15
Investing Cash Flow
-1.00
-150.54%
1.98
+127.39%
-7.23
-126.51%
-3.19
Cash Flow From Continuing Investing Activities
-1.00
-150.54%
1.98
+127.39%
-7.23
-126.51%
-3.19
Net PPE Purchase And Sale
-0.00
+99.20%
-0.06
-190.31%
-0.02
+90.96%
-0.22
Purchase Of PPE
-0.00
+99.20%
-0.06
-190.31%
-0.02
+90.96%
-0.22
Capital Expenditure
-1.00
-40.94%
-0.71
+85.04%
-4.74
-48.68%
-3.19
Capital Expenditure Reported
-1.00
-53.07%
-0.65
+86.17%
-4.73
-58.79%
-2.98
Net Investment Purchase And Sale
0.00
-100.00%
2.69
+208.28%
-2.48
0.00
Purchase Of Investment
0.00
+100.00%
-0.46
+96.47%
-13.04
0.00
Sale Of Investment
0.00
-100.00%
3.15
-70.16%
10.56
0.00
Net Intangibles Purchase And Sale
—
—
—
—
Purchase Of Intangibles
—
—
—
—
Financing Cash Flow
10.24
+76.04%
5.82
+8108.47%
0.07
+102.07%
-3.42
Cash Flow From Continuing Financing Activities
10.24
+76.04%
5.82
+8108.47%
0.07
+102.07%
-3.42
Net Issuance Payments Of Debt
—
—
0.00
+100.00%
-3.50
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
—
—
0.00
+100.00%
-3.50
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
—
—
0.00
+100.00%
-3.50
Net Long Term Debt Issuance
—
—
0.00
+100.00%
-3.50
Net Common Stock Issuance
5.75
+203.75%
1.89
0.00
0.00
Proceeds From Stock Option Exercised
0.00
-100.00%
4.55
+6314.99%
0.07
-9.86%
0.08
Net Other Financing Charges
-1.01
-61.89%
-0.62
—
—
Changes In Cash
5.00
+1175.19%
-0.47
+96.41%
-12.97
-4.30%
-12.43
Beginning Cash Position
1.88
-19.85%
2.34
-84.69%
15.31
-44.81%
27.74
End Cash Position
6.88
+266.31%
1.88
-19.85%
2.34
-84.69%
15.31
Free Cash Flow
-5.24
+41.59%
-8.97
+14.96%
-10.55
-17.13%
-9.01
Interest Paid Supplemental Data
0.00
-86.43%
0.01
-10.27%
0.02
-90.10%
0.16
Income Tax Paid Supplemental Data
—
—
—
0.00
Change In Interest Payable
—
—
0.00
+100.00%
-0.01
Common Stock Issuance
5.75
+203.75%
1.89
0.00
0.00
Issuance Of Capital Stock
11.25
+494.32%
1.89
0.00
0.00
Net Preferred Stock Issuance
5.50
0.00
—
—
Preferred Stock Issuance
5.50
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category